Form 8.3 - Nestor Healthcare Group Plc (8904Y)

TIDMNSR

RNS Number : 8904Y

GAM (UK) Ltd

04 January 2011

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

 
     (a) Identity of the person whose              GAM (UK) Limited 
     positions/dealings are being disclosed: 
------------------------------------------------  ---------------------------- 
     (b) Owner or controller of interests and 
     short positions disclosed, if different 
     from 1(a): The naming of nominee or vehicle 
     companies is insufficient 
------------------------------------------------  ---------------------------- 
     (c) Name of offeror/offeree in relation to    Nestor Healthcare Group PLC 
     whose relevant securities this form 
     relates: Use a separate form for each 
     offeror/offeree 
------------------------------------------------  ---------------------------- 
     (d) If an exempt fund manager connected 
     with an offeror/offeree, state this and 
     specify identity of offeror/offeree: 
------------------------------------------------  ---------------------------- 
     (e) Date position held/dealing undertaken:    31 December 2010 (Dealing) 
------------------------------------------------  ---------------------------- 
     (f) Has the discloser previously disclosed,   NO 
     or are they today disclosing, under the 
     Code in respect of any other party to this 
     offer? 
------------------------------------------------  ---------------------------- 
 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
 Class of relevant security:                       Ordinary GBP 0.10 
---------------------------------------  ------------------------------------- 
                                             Interests        Short positions 
---------------------------------------  -----------------  ------------------ 
                                           Number      %        Number      % 
---------------------------------------  ----------  -----  -------------  --- 
     (1) Relevant securities owned 
      and/or controlled:                  7,364,611   6.53 
---------------------------------------  ----------  -----  -------------  --- 
     (2) Derivatives (other than 
     options): 
---------------------------------------  ----------  -----  -------------  --- 
     (3) Options and agreements to 
     purchase/sell: 
---------------------------------------  ----------  -----  -------------  --- 
     TOTAL:                               7,364,611   6.53 
---------------------------------------  ----------  -----  -------------  --- 
 

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

 
 Class of relevant security in relation to which subscription 
  right exists: 
------------------------------------------------------------- 
 Details, including nature of the rights concerned 
  and relevant percentages: 
------------------------------------------------------------- 
 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c) copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

 
   Class of relevant     Purchase/sale   Number of securities   Price per unit 
       security 
----------------------  --------------  ---------------------  --------------- 
 Ord                     Purchase        3,434,593              1.095 
  Ord                     Sale            3,434,593              1.095 
----------------------  --------------  ---------------------  --------------- 
 

See note under Section 3

(b) Derivatives transactions (other than options)

 
  Class of       Product       Nature of dealing     Number of     Price per 
  relevant     description           e.g.            reference        unit 
  security       e.g. CFD      opening/closing a    securities 
                                  long/short 
                                   position, 
                              increasing/reducing 
                                 a long/short 
                                   position 
------------  -------------  --------------------  ------------  ------------- 
 
 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 
 Class of     Product      Writing,     Number of    Exercise   Type e.g.   Expiry    Option 
 relevant   description   purchasing,   securities    price     American,    date     money 
 security    e.g. call     selling,      to which      per      European              paid/ 
              option        varying       option       unit       etc.               received 
                             etc.        relates                                       per 
                                                                                       unit 
---------  ------------  ------------  -----------  ---------  ----------  -------  --------- 
 
 

(ii) Exercising

 
 Class of relevant        Product            Number of        Exercise price 
     security        description e.g.       securities           per unit 
                        call option 
------------------  ------------------  ------------------  ------------------ 
 
 

(d) Other dealings (including subscribing for new securities)

 
   Class of relevant      Nature of dealing     Details    Price per unit (if 
       security           e.g. subscription,                  applicable) 
                              conversion 
----------------------  ---------------------  --------  --------------------- 
 
 

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b) (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Note:

GAM International Management Ltd as discretionary investment manager has the following holdings for its funds:

GAM UK Diversified: 7,364,611 (6.526%)

Previous to this transaction, GAM UK Diversified had a position of 3,930 018 (3.482%), while another fund, GAM Exempt Trust, had a position of 3 434,593 (3.043%). GAM Exempt Trust has now sold its position to GAM UK Diversified and has no holdings in Nestor Healthcare Group Plc anymore.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

 
 Details of any indemnity or option arrangement, or 
  any agreement or understanding, formal or informal, 
  relating to relevant securities which may be an inducement 
  to deal or refrain from dealing entered into by the 
  person making the disclosure and any party to the 
  offer or any person acting in concert with a party 
  to the offer: 
  If there are no such agreements, arrangements or understandings, 
  state "none" 
------------------------------------------------------------------ 
 None 
------------------------------------------------------------------ 
 

(b) Agreements, arrangements or understandings relating to options or derivatives

 
     Details of any agreement, arrangement or understanding, 
      formal or informal, between the person making the 
      disclosure and any other person relating to: 
      (i) the voting rights of any relevant securities under 
      any option; or 
     (ii) the voting rights or future acquisition or disposal 
      of any relevant securities to which any derivative 
      is referenced: 
      If there are no such agreements, arrangements or understandings, 
      state "none" 
---------------------------------------------------------------------- 
 None 
---------------------------------------------------------------------- 
 

(c) Attachments

 
 Is a Supplemental Form 8 (Open Positions) attached?   NO 
----------------------------------------------------  --- 
 
 
 Date of disclosure:    4 January 2011 
---------------------  --------------- 
 Contact name:          John Morrissey 
---------------------  --------------- 
 Telephone number:      020-7917 2231 
---------------------  --------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [e-mail]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on [phone].

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETBIMATMBBMBMB